Parabilis Medicines, Inc. (PBLS)
NASDAQ · Healthcare
$27.31-7.58%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $95.07M
- P/E ratio
- —
- EPS
- —
- Volume
- 641,875
- 52-week high
- —
- 52-week low
- —
- Open
- $29.53
- Day high
- $30.21
- Day low
- $26.42
Financial highlights
Annual financials for Parabilis Medicines, Inc. are being compiled and will appear here soon.
About Parabilis Medicines, Inc.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
- CEO
- Mathai Mammen
- Employees
- 145
- Country
- US
- IPO date
- Jun 10, 2026
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Parabilis Medicines, Inc.'s stock price today?
- PBLS is trading at $27.31 as of Jul 20, 2026.
- What is Parabilis Medicines, Inc.'s market cap?
- Parabilis Medicines, Inc. (PBLS) has a market capitalization of $95.07M.
- What sector is Parabilis Medicines, Inc. in?
- Parabilis Medicines, Inc. operates in the Healthcare sector.